Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Sato

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Oecologia|March 18, 2017
Phenology and wintering capacity of sporophytes and gametophytes of ferns native to northern JapanToshiyuki Sato
Brain Research|September 3, 2004
Serum S-100b protein as a biomarker for the assessment of neuroprotectantsYasufumi Shirasaki, Naoko Edo, Toshiyuki Sato
Journal of Gastroenterology|March 24, 2023
Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammationShinichiro Shinzaki, Toshiyuki Sato, Hirokazu Fukui
European Journal of Pharmacology|July 6, 2010
Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversalYasufumi Shirasaki, Masunobu Sugimura, Toshiyuki Sato
Biomedical Microdevices|April 16, 2014
Evaluation of the effect of polymeric microneedle arrays of varying geometries in combination with a high-velocity applicator on skin permeability and irritationToshihiro Watanabe, Kei Hagino, Toshiyuki Sato
Pharmacology|March 31, 2004
DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in ratsToshiyuki Sato, Hideo Takamori, Yasufumi Shirasaki
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemiaToshiyuki Sato, Yoshiyuki Morishima, Yasufumi Shirasaki
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 9, 2025
[Efforts to reduce parenteral support in short bowel syndrome]Toshiyuki Sato, Yuki Horio, Shinichiro Shinzaki
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|June 14, 2005
Non-destructive observation of electrically detected magnetic resonance in bulk material using AC biasToshiyuki Sato, Hidekatsu Yokoyama, Hiroaki Ohya
Alimentary Pharmacology & Therapeutics|May 5, 2025
Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A Valuable but Preliminary Glimpse. Authors' ReplyShinichiro Shinzaki, Yasuhiro Takagi, Toshiyuki Sato
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Oecologia|March 18, 2017
Phenology and wintering capacity of sporophytes and gametophytes of ferns native to northern JapanToshiyuki Sato
Brain Research|September 3, 2004
Serum S-100b protein as a biomarker for the assessment of neuroprotectantsYasufumi Shirasaki, Naoko Edo, Toshiyuki Sato
Journal of Gastroenterology|March 24, 2023
Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammationShinichiro Shinzaki, Toshiyuki Sato, Hirokazu Fukui
European Journal of Pharmacology|July 6, 2010
Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversalYasufumi Shirasaki, Masunobu Sugimura, Toshiyuki Sato
Biomedical Microdevices|April 16, 2014
Evaluation of the effect of polymeric microneedle arrays of varying geometries in combination with a high-velocity applicator on skin permeability and irritationToshihiro Watanabe, Kei Hagino, Toshiyuki Sato
Pharmacology|March 31, 2004
DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in ratsToshiyuki Sato, Hideo Takamori, Yasufumi Shirasaki
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemiaToshiyuki Sato, Yoshiyuki Morishima, Yasufumi Shirasaki
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 9, 2025
[Efforts to reduce parenteral support in short bowel syndrome]Toshiyuki Sato, Yuki Horio, Shinichiro Shinzaki
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|June 14, 2005
Non-destructive observation of electrically detected magnetic resonance in bulk material using AC biasToshiyuki Sato, Hidekatsu Yokoyama, Hiroaki Ohya
Alimentary Pharmacology & Therapeutics|May 5, 2025
Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A Valuable but Preliminary Glimpse. Authors' ReplyShinichiro Shinzaki, Yasuhiro Takagi, Toshiyuki Sato
Pageof 13